Biosynthetic engineered B28K–B29P human insulin monomer structure in water and in water/acetonitrile solutions
- 312 Downloads
KeywordsTertiary Structure Human Insulin Insulin Lispro Insulin Detemir Dime Interface
This research was conducted mainly within the frame of a Key Research Project under contract No. POIG 01.01.01-14—007/08-00. Part of these results was a research project supported from Ministry of Science and Higher Education funds reserved for science during a period of 2009–2012.
- Borowicz P, Płucienniczak A, Mikołajczyk J, Głąbski T, Kurzynoga D, Mikiewicz-Syguła D, Wojtowicz-Krawiec A, Zieliński M, Kęsik-Brodacka M, Adamczewska-Cecuda V et al (2009) Institute of Biotechnology and Antibiotics assignee. Novel insulin analogues of prolonged activity. Patent WO 2010/002283. PolandGoogle Scholar
- Borowicz P, Bocian W, Sitkowski J, Bednarek E, Mikiewicz-Syguła D, Błażej-Sosnowska S, Bogiel M, Rusek D, Kurzynoga D, Kozerski L (2011) Novel recombinant insulin analogue with flexible C-terminus in B chain. NMR structure of biosynthetic engineered A22G–B31K-B32R human insulin monomer in water/acetonitrile solution. Int J Biol Macromol 49(4):548–554CrossRefGoogle Scholar
- Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB (2000) Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 49(12):2142–2148CrossRefGoogle Scholar